Pradaxa Sales Data
| Rank 75 |
Current sales rank, all
U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Pradaxa U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range |
Sales Rank |
Sales ($000) |
|
Units (000) |
|
| Q1 2013 |
75 ( 4) |
$215,003 |
4.76% |
983 |
-0.20% |
| Q4 2012 |
79 ( 4) |
$205,238 |
-1.83% |
985 |
-4.18% |
| Q3 2012 |
75 (1) |
$209,063 |
3.84% |
1,028 |
4.58% |
| Q2 2012 |
76 (5) |
$201,327 |
0.13% |
983 |
-2.77% |
| Q1 2012 |
81 (4) |
$201,065 |
5.13% |
1,011 |
6.53% |
| Q4 2011 |
85 (7) |
$191,260 |
16.27% |
949 |
16.30% |
| Q3 2011 |
92 ( ) |
$164,496 |
 |
816 |
|
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|
| November 8, 2012 | Boehringer Recalls Manufacturing Lot of Pradaxa |
| May 25, 2012 | European Medicines Agency Updates Patient and Prescriber Information for Pradaxa |
| December 8, 2011 | FDA Drug Safety Communication: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate) |
| July 21, 2011 | Pradaxa (dabigatran etexilate mesylate) Capsules Now on Formulary at Nation's Top Heart Hospitals |
| November 8, 2010 | New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients |
| October 20, 2010 | Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke |
| October 20, 2010 | Pradaxa Approved for Atrial Fibrillation |
| February 26, 2010 | Current Blood Thinners Face Tough Competition |
| December 7, 2009 | New Blood Thinner Could Replace Warfarin to Fight Venous Clots |
| November 18, 2009 | Newer Blood Thinners May Outperform Old Standbys |
| November 15, 2009 | Alternative to Warfarin May Cut Risk of Bleeding |
| August 30, 2009 | New Anti-Clotting Drug Beats Plavix |
4)
4)
)
